RYTM 8-K 2026-06-25

RHYTHM PHARMACEUTICALS, INC. (RYTM) 8-K dated 2026-06-25 — accession 0001628280-26-045569. This URL is the filing, not the RYTM hub.

RHYTHM PHARMACEUTICALS, INC. (RYTM) is a biotechnology company listed on NASDAQ.

RHYTHM PHARMACEUTICALS, INC. filed a 8-K on 2026-06-25. Accession 0001628280-26-045569.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RYTM revenue for 2026-06-30 was $131.4M. Net income was -$104.9M. RYTM currently screens at market cap $6.49B.

Not investment advice. The RYTM SEC hub lists recent forms. The stock page is the research view.